Prime Capital Investment Advisors LLC cut its holdings in Clorox Co (NYSE:CLX) by 84.3% during the 1st quarter, Holdings Channel reports. The firm owned 2,050 shares of the company’s stock after selling 11,000 shares during the period. Prime Capital Investment Advisors LLC’s holdings in Clorox were worth $329,000 at the end of the most recent reporting period.
Other hedge funds have also added to or reduced their stakes in the company. Athena Capital Advisors LLC acquired a new stake in shares of Clorox in the fourth quarter valued at approximately $25,000. Meeder Asset Management Inc. acquired a new stake in shares of Clorox in the fourth quarter valued at approximately $26,000. Capital Financial Planning LLC acquired a new stake in shares of Clorox in the fourth quarter valued at approximately $32,000. Paragon Capital Management LLC acquired a new stake in shares of Clorox in the first quarter valued at approximately $35,000. Finally, City Holding Co. boosted its position in Clorox by 150.0% during the fourth quarter. City Holding Co. now owns 250 shares of the company’s stock worth $39,000 after acquiring an additional 150 shares during the last quarter. Institutional investors and hedge funds own 76.90% of the company’s stock.
Shares of NYSE CLX opened at $152.34 on Wednesday. Clorox Co has a 1 year low of $113.57 and a 1 year high of $167.70. The company has a market cap of $19.79 billion, a P/E ratio of 24.34, a PEG ratio of 3.86 and a beta of 0.32. The company has a current ratio of 1.15, a quick ratio of 0.66 and a debt-to-equity ratio of 3.08.
Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, February 4th. The company reported $1.40 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.32 by $0.08. The company had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.47 billion. Clorox had a net margin of 12.65% and a return on equity of 105.97%. Clorox’s revenue was up 4.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.77 earnings per share. Sell-side analysts anticipate that Clorox Co will post 6.31 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be paid a dividend of $0.96 per share. This represents a $3.84 dividend on an annualized basis and a yield of 2.52%. The ex-dividend date is Tuesday, April 23rd. Clorox’s dividend payout ratio is currently 61.34%.
A number of brokerages recently issued reports on CLX. Zacks Investment Research lowered shares of Clorox from a “hold” rating to a “sell” rating in a research report on Tuesday. Wells Fargo & Co restated a “hold” rating and set a $157.00 target price on shares of Clorox in a research report on Monday, February 4th. Morgan Stanley set a $142.00 target price on shares of Clorox and gave the stock a “sell” rating in a research report on Thursday, December 20th. Citigroup set a $171.00 target price on shares of Clorox and gave the stock a “hold” rating in a research report on Tuesday, February 5th. Finally, JPMorgan Chase & Co. lowered shares of Clorox from a “neutral” rating to an “underweight” rating and decreased their target price for the stock from $159.00 to $139.00 in a research report on Monday, April 8th. Six research analysts have rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating to the company’s stock. Clorox presently has an average rating of “Hold” and a consensus target price of $151.21.
In other Clorox news, SVP Andrew J. Mowery sold 5,340 shares of the stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $156.44, for a total transaction of $835,389.60. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, SVP Matthew T. Laszlo sold 10,585 shares of the stock in a transaction that occurred on Wednesday, February 6th. The stock was sold at an average price of $153.89, for a total transaction of $1,628,925.65. Following the transaction, the senior vice president now directly owns 17,994 shares in the company, valued at approximately $2,769,096.66. The disclosure for this sale can be found here. Company insiders own 1.40% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Prime Capital Investment Advisors LLC Lowers Stake in Clorox Co (CLX)” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2019/04/17/prime-capital-investment-advisors-llc-lowers-stake-in-clorox-co-clx.html.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Recommended Story: Insider Trading
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.